| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | -10.4% | -16.2% |
| Cost of Revenue | $1.6M | -23.6% | -4.5% |
| Gross Profit | -$411K | +46.0% | -58.3% |
| R&D Expense | $2.9M | +14.2% | +25.8% |
| SG&A Expense | $2.6M | -6.6% | -40.8% |
| Operating Income | -$7.5M | +4.6% | +19.4% |
| Pre-tax Income | -$7.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.6M | +29.5% | +58.4% |
| Accounts Receivable | $1.0M | -15.6% | -61.7% |
| Inventory | $2.9M | -12.4% | -70.5% |
| Current Assets | $28.2M | +21.0% | -1.7% |
| Total Assets | $42.5M | +15.1% | +1.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.2M | — | — |
| Capital Expenditures | $1.7M | — | — |
| Investing Cash Flow | -$2.1M | — | — |
| Financing Cash Flow | $19.7M | — | — |
| Free Cash Flow | -$14.9M | — | — |
| +4.1% |
| +20.3% |
| Net Income | -$7.4M | +4.1% | +20.3% |
| EPS (Basic) | -$0.09 | +10.0% | +35.7% |
| EPS (Diluted) | -$0.09 | +10.0% | +35.7% |
| $4.0M |
| +30.2% |
| +81.3% |
| Total Liabilities | $4.6M | — | +100.0% |
| Stockholders' Equity | $27.9M | -3.4% | -29.5% |